| Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ... Clinical Infectious Diseases 62 (8), 995-1001, 2016 | 164 | 2016 |
| Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable … K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ... The lancet Respiratory medicine 5 (4), 269-281, 2017 | 148 | 2017 |
| Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa O Olayanju, J Limberis, A Esmail, S Oelofse, P Gina, E Pietersen, M Fadul, ... European respiratory journal 51 (5), 2018 | 125 | 2018 |
| The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis K Dheda, T Gumbo, G Maartens, KE Dooley, M Murray, J Furin, ... The Lancet Respiratory Medicine 7 (9), 820-826, 2019 | 107 | 2019 |
| Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis N Ismail, E Rivière, J Limberis, S Huo, JZ Metcalfe, RM Warren, A Van Rie The Lancet Microbe 2 (11), e604-e616, 2021 | 41 | 2021 |
| A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis O Olayanju, A Esmail, J Limberis, K Dheda European Respiratory Journal 55 (1), 2020 | 39 | 2020 |
| Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis G Theron, J Limberis, R Venter, L Smith, E Pietersen, A Esmail, ... Nature medicine 26 (9), 1435-1443, 2020 | 37 | 2020 |
| Same-day tools, including Xpert Ultra and IRISA-TB, for rapid diagnosis of pleural tuberculosis: a prospective observational study R Meldau, P Randall, A Pooran, J Limberis, E Makambwa, M Dhansay, ... Journal of clinical microbiology 57 (9), 10.1128/jcm. 00614-19, 2019 | 37 | 2019 |
| A human lung challenge model to evaluate the safety and immunogenicity of PPD and live Bacillus Calmette-Guérin M Davids, A Pooran, C Hermann, L Mottay, F Thompson, J Cardenas, ... American journal of respiratory and critical care medicine 201 (10), 1277-1291, 2020 | 34 | 2020 |
| Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis CC Naidoo, GR Nyawo, I Sulaiman, BG Wu, CT Turner, K Bu, Z Palmer, ... EBioMedicine 67, 2021 | 30 | 2021 |
| Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen O Olayanju, A Esmail, J Limberis, P Gina, K Dheda International Journal of Infectious Diseases 85, 74-79, 2019 | 29 | 2019 |
| A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic M Klopper, TH Heupink, G Hill-Cawthorne, EM Streicher, A Dippenaar, ... BMC medicine 18, 1-14, 2020 | 24 | 2020 |
| Selected questions and controversies about bedaquiline: a view from the field K Dheda, A Esmail, J Limberis, G Maartens The International Journal of Tuberculosis and Lung Disease 20 (12), S24-S32, 2016 | 15 | 2016 |
| Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment SB Georghiou, TC Rodwell, A Korobitsyn, SH Abbadi, K Ajbani, ... European Respiratory Journal 59 (4), 2022 | 11 | 2022 |
| Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study B Derendinger, A Dippenaar, M de Vos, S Huo, R Alberts, R Tadokera, ... The Lancet Microbe 4 (12), e972-e982, 2023 | 10 | 2023 |
| Comparative performance of genomic methods for the detection of pyrazinamide resistance and heteroresistance in Mycobacterium tuberculosis MG Whitfield, DM Engelthaler, C Allender, M Folkerts, TH Heupink, ... Journal of clinical microbiology 60 (1), e01907-21, 2022 | 8 | 2022 |
| High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South Africa B Derendinger, A Dippenaar, M de Vos, S Huo, R Alberts, R Tadokera, ... medRxiv, 2022.11. 14.22282167, 2022 | 6 | 2022 |
| Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection W Zheng, IC Chang, J Limberis, JM Budzik, BS Zha, Z Howard, L Chen, ... bioRxiv, 2023 | 3 | 2023 |
| Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants S Jaumdally, M Tomasicchio, A Pooran, A Esmail, A Kotze, S Meier, ... Nature Communications 15 (1), 2003, 2024 | 1 | 2024 |
| uDumBell–Circularization of rv0678 for genotypic bedaquiline resistance testing of Mycobacterium tuberculosis JD Limberis | 1 | 2023 |
Keertan DhedaProfessor, University of Cape Town & London School of Hygiene and Tropical MedicineVerified email at uct.ac.za
